fbpx
Request Support
Request Info

Resources

Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance

Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance

Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance
Expands office-based treatment options for millions of non-melanoma skin cancer (NMSC) patients
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, announced its Radiant™ Aura treatment solution has received U.S. Food and Drug Administration (FDA) 510(k) clearance. With advanced features for expanded clinical use, simplified patient positioning, and additional patient comfort, Radiant Aura brings radiation therapy to NMSC patients in any dermatology office. 

read more
Two Case Histories: Office-Based Radiation Therapy for the Dermatology Clinic

Two Case Histories: Office-Based Radiation Therapy for the Dermatology Clinic

Dr. Sean E. Mazloom, MD, FAAD, from ReJUVA Dermatology, Vein & Skin Cancer Center, Venice, FL has been using the RADiant system to treat both squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) in his practice. Depending on a number of factors specific to each patient, he has treated these conditions with superficial radiation therapy (SRT) and electronic brachytherapy (eBT). Below are two case studies that describe the treatment process and results.

read more
kV Radiotherapy Treatment in Locally Advanced or Metastatic Breast Cancer

kV Radiotherapy Treatment in Locally Advanced or Metastatic Breast Cancer

Researchers sought to understand the role of kV treatment in locally advanced and/or metastatic breast cancer in which kV radiotherapy was used as the primary modality or as supportive treatment to linac-based RT to gain local tumor control and improve the patient’s quality of life. See details of the recent study, Kilovoltage radiotherapy as a supportive treatment in locally advanced or metastatic breast cancer – a series of six case reports, and the full report on six cases.

read more
Treating My Skin Cancer with Superficial Radiation Therapy was the Perfect Alternative to Surgery

Treating My Skin Cancer with Superficial Radiation Therapy was the Perfect Alternative to Surgery

Myrna has a history of multiple skin cancers that were treated with Mohs micrographic surgery. During the last year, Myrna was diagnosed twice with basal cell carcinomas (BCC). Her dermatologist, Dr. John Binhlam of Advanced Skin & Laser Center, in Brentwood, Tennessee recommended superficial radiation therapy (SRT) as an alternative to Mohs surgery based on several factors unique to her. Myrna had SRT treatment delivered with the RADiant system, right in Dr. Binhlam’s office.

read more
Evaluation of Radiation Therapy of Ocular Tumours

Evaluation of Radiation Therapy of Ocular Tumours

Xstrahl in Action A recent study investigated reduced risk of damage to nearby organs during the treatment of ocular tumours. using our Small Animal Radiation Research Platform (SARRP). Publication Orthovoltage X-ray Minibeam Radiation Therapy for the Treatment of...

read more
Superficial Radiation Therapy was a Simple Choice for My Skin Cancer

Superficial Radiation Therapy was a Simple Choice for My Skin Cancer

Marcia is 74 years old and a great-grandmother from Bell Buckle, Tennessee. Last year, she noticed bleeding from a tiny spot on the tip of her nose. At her next appointment, she had her dermatologist, Dr. John Binhlam, take a closer look. He did a biopsy on the spot, and she was diagnosed with an invasive squamous cell carcinoma (SCC) of the nasal tip. After a discussion of Mohs micrographic surgery versus nonsurgical superficial radiation therapy (SRT), Marcia chose to have the latter treatment done using the RADiant system at his office, Advanced Skin & Laser Center in Brentwood, Tennessee.

read more

Contact Us

Find out more about how Xstrahl will work tirelessly for you

Contact Us

Explore Related Categories

Area of Interest
Products